REG - ConvaTec Group PLC - Director Declaration

ConvaTecAnnouncement

07/10/2020 11:50

RNS Number : 3958B
  
ConvaTec Group PLC
  
07 October 2020
  
 

ConvaTec Director Declaration
Reading, United Kingdom (7 October 2020)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Rick Anderson, a Non-Executive Director of the Company, has been appointed to the Board of Directors of Silk Road Medical, Inc. (Nasdaq: SILK), with effect from 1 October 2020. 
This announcement is made in accordance with Listing Rule 9.6.14R.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations & 
Corporate Communications, ConvaTec                                    +44 (0)7826 447807
ir@convatec.com
 
Media
Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                 
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
 
 
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RDNUPGPCUUPUGUM